Azitra is trading 5.3% higher at $0.14 after-hours, versus its October 6 regular-session close of $0.13; no company-specific announcement explaining the move was found for October 6.

  • The latest reported company news was an October 1 update that ATR04-484 could advance to Cohort 2 after a safety review, before this move.
  • The S&P 500, Nasdaq, and Dow each rose more than 0.5% on October 6; this is a possible backdrop, not a confirmed cause.